Sort   by:  
 Page size 
GenomicsTargeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia
Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia
PRJNA1057163 | ENA
TranscriptomicsTargeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia
Novel therapeutic approaches for addressing pneumonia caused by Streptococcus pneumoniae, which exhibit resistance to standard-of-care antibiotics are greatly needed. One viable approach involves precisely stimulating innate immune defenses within the lungs. Using murine models of pneumococcal pneum...
ORGANISM(S): Mus musculus 
2024-10-11 | GSE252037 | GEO
UnknownDroplet delivery and nebulization system using surface acoustic wave for mass spectrometry.
Not available
S-EPMC11810141 | biostudies-literature
UnknownInhaled antibodies: formulations require specific development to overcome instability due to nebulization.
Not available
S-EPMC7993445 | biostudies-literature
UnknownTargeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia.
Not available
S-EPMC11619323 | biostudies-literature
UnknownInnovative nebulization delivery of lipid nanoparticle-encapsulated siRNA: a therapeutic advance for Staphylococcus aureus-induced pneumonia.
Not available
S-EPMC11481290 | biostudies-literature
UnknownLow energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery.
Not available
S-EPMC10231294 | biostudies-literature
TranscriptomicsFlagellin nebulization enhances respiratory immune responses in the porcine model
Respiratory delivery of the Toll-like receptor 5 agonist FLAMOD, a recombinant flagellin, offers a promising approach for treating bacterial pneumonia. FLAMOD stimulates the airway epithelium, mobilizing and activating immune cells and effectors to combat infections. While previous evidences were ob...
ORGANISM(S): Sus scrofa 
2025-02-19 | GSE289859 | GEO
UnknownViability assessment of human peripheral blood-derived stem cells after three methods of nebulization.
Not available
S-EPMC8610807 | biostudies-literature
UnknownNebulization of siRNA for inhalation therapy based on a microfluidic surface acoustic wave platform.
Not available
S-EPMC9263997 | biostudies-literature
Sort   by:  
 Page size